ALMS1 Inhibitors
ALMS1 inhibitors are a specialized class of chemical compounds designed to target the ALMS1 (Alström Syndrome 1) protein. ALMS1 is a large protein associated with the development of Alström syndrome. The precise functions of ALMS1 are still under investigation, but it is known to be involved in various cellular processes, including ciliary function and intracellular trafficking.
Inhibitors of ALMS1 are designed to interact with this protein and disrupt its cellular functions or interactions with other cellular components. These inhibitors may operate through various mechanisms, such as binding to specific domains of ALMS1 or altering its conformation. By inhibiting ALMS1, these compounds can interfere with the processes related to ciliary function and intracellular trafficking, offering insights into the molecular mechanisms underlying Alström syndrome and the roles of ALMS1 in cellular physiology. Research on ALMS1 inhibitors is primarily focused on understanding how this protein contributes to the pathogenesis of Alström syndrome and its involvement in cellular processes, shedding light on the complex cellular pathways that are affected by mutations in the ALMS1 gene.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
A topoisomerase I inhibitor, which could impede transcriptional elongation and potentially downregulate ALMS1 expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor, it can alter chromatin structure and gene expression, possibly affecting ALMS1 transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
This compound binds to DNA and inhibits RNA synthesis, potentially decreasing ALMS1 mRNA. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
A compound that binds to DNA and can inhibit RNA polymerase, possibly affecting ALMS1 transcription. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
A glucose analog that inhibits glycolysis, potentially leading to energy stress and downregulation of some genes. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
A folate analog that inhibits dihydrofolate reductase, leading to reduced nucleotide synthesis and potential downregulation of DNA replication-dependent gene expression. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Inhibits topoisomerase II, potentially suppressing gene expression through interference with DNA replication and transcription. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
A cyclin-dependent kinase inhibitor that may alter cell cycle progression and gene expression, potentially influencing ALMS1. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
An anthracycline compound that intercalates DNA and inhibits topoisomerase II, which may lead to reduced transcription of various genes including ALMS1. | ||||||
Mevastatin (Compactin) | 73573-88-3 | sc-200853 sc-200853A | 10 mg 50 mg | $77.00 $179.00 | 18 | |
An HMG-CoA reductase inhibitor that could theoretically influence gene expression by altering lipid rafts and membrane-associated signaling. | ||||||